Sendai Virus nucleoprotein (324-332) – Antimicrobial Peptides – AMP

The identification of T cell epitopes is vital for a range of immunological functions including viral vaccine design. Current influenza vaccines are designed to induce protective humoral immunity by exposure to inactivated influenza leading to an induction of potent CD4+ T cell memory. However, little is known about how these primed CD4+ T cells effect the response to other viruses that share a common T cell epitope. Sendai Virus nucleoprotein (324-332) has been identified as a T cell epitope and used in T cell assays to stimulate a response. Further use of Sendai virus nucleoprotein (324-332) epitope in vitro could help uncover the effect of immune response to heterologous viruses with common epitopes. It may also help understand the impact of using primed CD4+ T cell as vaccines. This could have consequences for future vaccine design to improve specificity and potency of the immune cells.